EHRA is looking for a specialist to provide long-term maintenance and support for both harmreductioneurasia.org and eecaplatform.org websites. Application deadline is October 1, 2018. Please see the detailed Terms of Reference to familiarize yourself with the tasks, requirements and conditions. Applications can be submitted by contacting Irena Zubkova at email@example.com
On 17-30 of September, 2018 EHRA conducts online Regional Meetings of its members to elect new Steering Committee representatives in the following regions:
- Central Europe (Poland, Slovakia, Czech Republic, Hungary, Slovenia);
- Caucasus (Armenia, Azerbaijan, Georgia);
- Central Asia (Kazakhstan, Kyrgyzstan, Tajikistan, Uzbekistan, Turkmenistan).
At the same time, General meeting of EHRA members to elect Steering Committee representatives from the community of people who use drugs will be conducted.
All members (individual and organizational), who are from the above-mentioned regions (in case of Regional meeting) and also who are identifying themselves as members of the community of people who use drugs (in case of General meeting) have a right to vote in the General and Regional meetings.
If you have any questions, please contact General Secretary of the General and Regional meetings – Irena Zubkova at firstname.lastname@example.org
Eurasian Harm Reduction Association (hereinafter EHRA) announces the tender for providers of printing services (preparation for printing and printing of information materials) for long-term cooperation in Lithuania.
Dear EHRA members,
Eurasian Harm Reduction Association (EHRA) (Eurazijos žalos mažinimo asociacija), registered at Gedimino pr. 45-4, Vilnius 01109, Lithuania (actual address Verkių g. 34B-701, Vilnius) announces the convocation of the members regional meetings from the particular regions: Central Europe, Ukraine-Moldova-Belarus, Caucasus, Central Asia and community of people who use drugs.
Please, find a list of all current Steering Committee members.
A list of Steering Committee members subject to rotation in the Regional meetings:
- Iveta Chovancova (Central Europe)
- Leonid Vlasenko (Ukraine-Moldova-Belarus)
- Nino Tsereteli (Caucasus)
- Maram Azizmamadov (Central Asia)
A list of Steering Committee members subject to rotation in the General meeting:
- Alla Asaeva (community of PWUD)
- Viktoria Lintsova (community of PWUD)
Schedule of elections:
- From 27 August, 2018 to 16 September, 2018 – nomination process (3 weeks). Candidates are submitting their applications to become a member of the Steering Committee
- From 17 to 30 September, 2018 – online voting to elect Steering Committee members in four above-mentioned regions and from the community of PWUD
- 1st October, 2018 – announcement of the results.
We are inviting all EHRA members from the above-mentioned regions to submit applications to become a member of the Steering Committee until 16 September 2018.
The requirements for the candidates are:
- be a member of EHRA;
- demonstrate readiness and ability to work responsibly and actively as a Steering Committee member;
- follow the principles listed in the Association Steering Committee Regulations;
- to reside within a region participating in the current elections;
- to avoid a potential conflict of interests, candidates cannot be representatives of Association’s donor organizations.
IMPORTANT INFORMATION FOR THE CANDIDATES! According to the Regulations of the Steering Committee of EHRA, a country represented in a particular region may have only one representative in the Steering Committee who is elected through regional elections (Regional Meetings). This means, that members from Czech Republic, Ukraine and Kazakhstan can’t apply for the SC elections.
Representatives of the community of people who use drugs represent the Association’s whole geographical area and should be from different countries. So we are inviting all EHRA members, who represent community of PWUD to apply to SC elections, to represent community of PWUD.
If you have any questions, please do not hesitate Secretary of the Regional meetings Eliza Kurcevic, on e-mail: email@example.com
Authors: Olga Belyaeva, Advocacy Manager, EHRA/Sergei Bessonov, “Harm Reduction Network” Association, Kyrgyzstan
“Don’t push us into the corner or we will shoot”. Who pushes people into the corner introducing new Criminal Codes under the guise of “humane reforms” and reducing the prison population in Kyrgyzstan while three grams of hashish are subject to a fine of 4000 dollars?! If you don’t pay the fine they’ll put you in prison for up to 5 years. And most importantly, how can we change the vector of drug policy toward regulation of psychoactive substances, safe drug use with adequate restrictions that keep people in the legal field and give possibilities of comfortable drug use?
This is the topic of our meeting during the Dialogue Platform “Challenges for the communities and definition of responsive measures”, organized by the Kyrgyzstan Harm Reduction Association with assistance from the Eurasian Harm Reduction Association and AFEW Kyrgyzstan.
Platform discussion topics: geopolitical relations between countries, stigma influenced by religion, the history of cannabis and opium in Kyrgyzstan. How and why did people change the methods of substance use, real risks and consequences of such actions and how can we respond to them in our harm reduction programs. In fact, we see that programs and approaches of harm reduction services are not in the same street with the actual needs of people. We also discussed the pilot project that would start in one of the districts in Bishkek in 2019, based on the LEAD model and led by AFEW. The basic indicators of the desired results of the pilot are community monitoring, including street lawyers / public defenders, personal contacts, statistics monitoring of drug related cases in police, probation and courts.
The country is currently reviewing the Government Regulation № 543 on drug quantities: small, large and extremely large. Small quantity qualifies for a misconduct, while large and extremely large quantities are considered a criminal offense. Small quantities will remain in the Regulation, for example, a small quantity for heroin is up to 1 gram. The big step forward is that the expertise on the drug purity was included to the Regulation. Basically, it’s a good topic to consider. If a person is detained with 1.5 grams of a drug, the person perpetrates the Criminal Code, which means 4 000 dollars fine or a prison. Then, the expertise might show that the pure substance is less than one gram, this means the person breaks the law of the Misdemeanor Code and can be subject to a fine of 800 dollars and a restriction of freedom for 6 months (the person would also be banned from visiting certain places or will be subjected to treatment according to their consent and at their expense). The problem in this case is that the actual situation on the drug stage is not taken into account, where the minimum purchase of heroin begins at five or ten grams.
“Fine for freedom” (c). People who feel and understand their freedom may create such slogans. And we know that our message will be convincing only if we accept ourselves as people for whom the use of psychoactive substances is a standard of living. We should expose to the thinking people the causal relationship between bribes, provocations, blackmail by policy and suicide, homelessness, pain and all negative consequences of repressive drug policies, which could have been prevented.
1 000 dollars are spent for incarceration of one person per year while opiate substitution therapy and needle exchange programs cost only 280 dollars and give you freedom. Drug policy and appropriate use of public budget are two halves of the same objective: decriminalization as a step towards the regulation of substances and redirection of resources from repression to helping people with drug dependency. Tomorrow the participants of the Dialogue Platform will clarify the strategic goals and tactical plans to blaze a trail to freedom and implementation of the constitutional rights in their country.
The session on “Connecting NGO and communities representatives from Eastern Europe and Central Asia with 3 Delegations to the Global Fund Board” was held in the The Global Fund Community Zone of the Global Village at the XXII International AIDS Conference (AIDS 2018) on 25 July, 2018.
On 24 July, 2018, EHRA and Canadian HIV/AIDS Legal Network conducted a workshop “Handle with Care: How to Document Human Rights Violations among the Most Vulnerable Groups of Key Populations”.
On 26 July, 2018, at the 22 International AIDS Conference in Amsterdam, EHRA hold a consultation on the areas of drug policy reform in the Central and Eastern Europe and Central Asia (CEECA) region.
Dear colleagues, dear EHRA members!
Eurasian Harm Reduction Association (EHRA) is launching a regional online consultation to define its priorities in the area of drug policy and human rights of people who use drugs in CEECA that would guide our future activities in 2018 – 2020. The strategic framework of our organization contains the following objective: advocacy of non-repressive drug policy in CEECA, based on public health and human rights. We need a more detailed general position of the organization with a clear vision of expected outcomes supported by the majority of EHRA members for policy and advocacy work.
We expect that this consultation will result in a joint position of EHRA on drug policy, which will reflect our common vision of drug policy in the countries of our region in the future and will identify key approaches to achieve that objective with the help of EHRA members at the national level and by our common efforts at the regional and global level.
This consultation is intended to help us to:
– Jointly explore trends in drug policy in our countries and sub-regions, the impact of political, economic, cultural and religious factors on possible drug policy reforms and understand what should be changed in order to achieve our goals.
– Share the views among EHRA members on drug policy reform and define common regional priorities in drug policy. To achieve this, we need to understand if the Association is ready to set ambitious goals for drug policy reform such as legalization/regulation of drugs – or if we should focus on promoting alternatives to punishment at this stage, without changing the existing legal prohibition framework.
– Discuss if it is realistic for EHRA to engage in “drugeconomics“: the analysis of the economic impact of repressive drug policy and the effectiveness of funding law enforcement approaches to “combat drug abuse”, discussing advocacy issues of redistribution of public funding from law enforcement to social support, harm reduction and re-socialization programs.
– Explore the initiatives and projects of the community aimed at decriminalization, protecting social and economic rights of people who use drugs and OST clients, and document the approaches that have shown positive results in drug policy reform in our region.
The consultation will also help EHRA improve its expert knowledge of drug policy and develop a regional expert database.
The consultation will be held in several stages:
Step 1: Analysis of human rights violations
EHRA will continue to collect information on systematic violations of human rights, achievements and issues faced of people who use drugs, best practices and the results of community-led projects in the field of drug policy and advocacy, in order to develop a regional review. The consequent working stage of this activity took place in May 2018 when the Global Commission on HIV and the Law announced its call for submissions of complaints and best practices . If you did not have the opportunity to do this before May 15, you still may send a short description of violations of the rights of people who use drugs or a description of the results of advocacy and drug policy projects.
Timeline: until September 1, 2018
Please send your submissions or to Dasha Matyushina-Ocheret, firstname.lastname@example.org
Step 2: Webinars “Drug Policy: threats and opportunities”
We will conduct a series of webinars that will allow you to learn more about drug policy and voice your questions and opinions. It will also help us to ensure that EHRA position is based on scientific evidence and analysis of the consequences of repressive drug policy as well as the experience of countries with progressive drug policy.
EHRA will conduct a series of webinars on drug policy, to introduce the members of the Association to the key international and regional trends:
- July 17: Alternatives to punishment for drug use and possession of drugs
- July 31: Decriminalization, depenalization, legalization – what does it all mean in practice?
- August 14: The rights of people who use drugs, or the right to use drugs: what do the international law and common sense tell us?
- August 28: International drug policy: the preparation to the HLM on Drugs 2019
All webinars will be conducted and recorded in Russian and English. We will develop a series of information materials in Russian and English to distribute before the webinars start.
Step 3: Face-to-face consultation during the AIDS Conference in Amsterdam: “How does the repression of people who use drugs interfere with the response to HIV, TB and viral hepatitis in EECA? Are we ready to change the situation? “
The discussion on priorities of drug policy in CEECA will take place in the Regional EECA Space of the Global Village on July 26, 2018. Members of EHRA as well as other activists will take part in the debate. The objective of the consultation is to develop a common vision of the drug policy reform in CEECA and determine the priorities for advocacy at the regional and national levels during a live discussion.
Main issues to discuss:
– Overview of the data on impact of current drug policies on access of PWID to prevention, testing and treatment of HIV, hepatitis and TB. Country cases demonstrating the barriers created by criminalization;
-The wording of key regional priorities to counter repressive drug policies at the national and regional levels;
– Discussion of opportunities associated with the implementation of alternatives to punishment, focusing on sustainability of harm reduction services in CEECA;
– Creating partnerships and finding allies for effective advocacy for drug policy reforms at the national and regional level.
The discussion is open to all EHRA members involved in AIDS2018, as well as to partner NGOs and community networks.
The discussion will be broadcast online to ensure that the maximum number of EHRA members and partners could take part in the consultation.
We will develop a draft position of EHRA on drug policy based on the results of the consultation.
Step 4: Online discussion of the draft drug policy position
A draft of EHRA drug policy position develop in August 2018 and will be shared online for review by the members of the association and partner organizations. Several calls will be held to discuss the wording of the position, there will be an opportunity to make edits and suggestions in writing as well.
Timeline: 1-31 August 2018
Step 5: Approval of EHRA Drug Policy Position by the Steering Committee.
Timeline: September 2018
We are going to use the following communication platforms to ensure that the maximum number of EHRA members can take part in the discussion:
– the EHRA members list-serve
– a Facebook group